Storia in 10 fonti

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and up

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 mese fa

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

FDA unanimously backed Moderna's mRNA flu vaccine (26.6-27.4% efficacy) for adults 50+, despite HHS defunding mRNA research. mRNA's 2-3 month reformulation vs. 6-8 month traditional manufacturing strengthens pandemic preparedness and supply chain agility.

originale

Timeline cronologica

martedì 16 giugno 2026·biopharmadive.com
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this…
martedì 16 giugno 2026·medpagetoday.com
FDA Staff Weighs In on Potential First mRNA Flu Shot
Moderna's novel vaccine was at the center of dustup with agency earlier this year

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

Confronto fonti

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

Timeline cronologica

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine

FDA Staff Weighs In on Potential First mRNA Flu Shot

Key FDA committee unanimously recommends its first vaccine since 2023

Moderna flu vaccine wins unanimous support from FDA panel

FDA panel recommends Moderna’s mRNA flu shot for older adults

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)

Key FDA committee unanimously recommends its first vaccine since 2023

Moderna flu vaccine wins unanimous support from FDA panel

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

FDA panel recommends Moderna’s mRNA flu shot for older adults

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR